» Articles » PMID: 7505976

Significance of Different Molecular Forms of Serum PSA. The Free, Noncomplexed Form of PSA Versus That Complexed to Alpha 1-antichymotrypsin

Overview
Specialty Urology
Date 1993 Nov 1
PMID 7505976
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Prostate specific antigen is an abundant prostate-derived serine protease in the seminal fluid. Low concentrations of the protein are normally released into blood, but above normal concentrations are frequently detected in prostate disease. The PSA-ACT complex is the predominant molecular form of serum PSA (up to approximately 95%) although complex formation is slow between the purified proteins in vitro. A free, noncomplexed form of PSA constitutes a minor fraction of the serum PSA, although serum ACT occurs in large molar excess. The free, noncomplexed form of serum PSA is reported to constitute a significantly smaller proportion of the PSA in untreated prostate cancer than in BPH. The molecular basis for this finding is unclear, but measurements of the proportion of the free form of serum PSA or the proportion of serum PSA-ACT may facilitate discrimination between prostate cancer and BPH.

Citing Articles

Immunochemical Assays and Nucleic-Acid Detection Techniques for Clinical Diagnosis of Prostate Cancer.

Kanyong P, Rawlinson S, Davis J J Cancer. 2016; 7(5):523-31.

PMID: 26958088 PMC: 4780128. DOI: 10.7150/jca.13821.


Assays for prostate cancer : changing the screening paradigm?.

Hansen J, Rink M, Graefen M, Shariat S, Chun F Mol Diagn Ther. 2013; 17(1):1-8.

PMID: 23355098 DOI: 10.1007/s40291-013-0014-y.


Tumor markers in prostate cancer I: blood-based markers.

Shariat S, Semjonow A, Lilja H, Savage C, Vickers A, Bjartell A Acta Oncol. 2011; 50 Suppl 1:61-75.

PMID: 21604943 PMC: 3571678. DOI: 10.3109/0284186X.2010.542174.


[-2]Proenzyme prostate specific antigen is more accurate than total and free prostate specific antigen in differentiating prostate cancer from benign disease in a prospective prostate cancer screening study.

Le B, Griffin C, Loeb S, Carvalhal G, Kan D, Baumann N J Urol. 2010; 183(4):1355-9.

PMID: 20171670 PMC: 3537165. DOI: 10.1016/j.juro.2009.12.056.


Management of elevated prostate-specific antigen in men with nonbacterial chronic prostatitis.

Sandhu J Curr Urol Rep. 2009; 10(4):302-6.

PMID: 19570492 DOI: 10.1007/s11934-009-0049-0.